Skip to content

Can massage therapy help improve the pain and discomfort caused by knee osteoarthritis and increase quality of life?

Evaluation of the efficacy of Ghamz therapy for the improvement of clinical symptoms and quality of life in patients with mild to moderate knee osteoarthritis

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT20251001067443N1
Enrollment
72
Registered
2025-11-27
Start date
2025-11-22
Completion date
Unknown
Last updated
2025-12-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Knee osteoarthritis. Bilateral primary osteoarthritis of knee

Interventions

Intervention 1: Intervention group: Ghamz (a type of deep tissue massage applied to specific points of the body) will be administered for 7 weeks, with one session per week. In parallel, home-based ac

Sponsors

Shahed University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
36 Years to No maximum

Inclusion criteria

Inclusion criteria: From 36 years old and above Knee pain for more than 3 months, at least 3 on the VAS scale in activities such as going up and down stairs or sitting and squatting Diagnosis of knee osteoarthritis based on clinical criteria + ACR radiography Grade one or two on knee radiographs based on the Kellgren Lawrence system Ability to perform the desired exercises

Exclusion criteria

Exclusion criteria: Use of sedatives, narcotics, muscle relaxants, or other undefined analgesics within 2 weeks prior to the start of the study. Intra-articular steroid injection within 3 weeks or systemic steroid administration within 2 weeks prior to the start of the study. Platelet-rich plasma (PRP) injection within the past 6 months. Ozone therapy within the past 3 months. Intra-articular injection of hyaluronic acid gel within the past 6 months. Use of topical herbal treatments, thermal therapy, or acupuncture within 2 weeks prior to the start of the study. Presence of severe neuropathy or significant neuromuscular disease that prevents the patient from tolerating the intervention. Presence of knee pain due to causes other than osteoarthritis. Presence of an open wound on the knee surface. History of severe knee trauma or previous knee or lower limb surgery. History of malignancy.

Design outcomes

Primary

MeasureTime frame
WOMAC questionnaire score. Timepoint: Before the start of the intervention, after 7 weeks of intervention, and at the end of week 11. Method of measurement: WOMAC questionnaire.;Pain. Timepoint: Before the start of the intervention, after 7 weeks of intervention, and at the end of week 11. Method of measurement: Visual Analysis Score(VAS).;Knee range of motion (ROM). Timepoint: Before the start of the intervention, after 7 weeks of intervention, and at the end of week 11. Method of measurement: Goniometer.

Secondary

MeasureTime frame
Quality of Life. Timepoint: Before the start of the intervention, after 7 weeks of intervention, and at the end of week 11. Method of measurement: Quality of Life Questionnaire(SF12).;Diclofenac consumption. Timepoint: Before the start of the intervention, after 7 weeks of intervention, and at the end of week 11. Method of measurement: Patient self-report.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactAlireza Azadkhani

Shahed University

alireza.azadkhani@gmail.com+98 21 5121 5080

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026